Navigation Links
Legalization of Therapeutic Abortion in UAE on the Cards

A senior official of the United Arab Emirates (UAE) said the government is working to draft a law allowing therapeutic abortions, as part of the country's prevention// programme of genetic disorders.

"We are studying it from two ways: on the mother or child's health. But the choice to have the abortion will be under the umbrella of religion. Whatever we decide has to be within the religious and social environment," Ali Shakar of the ministry of health was quoted as saying in Gulf News Thursday.

According to the draft law, it will be legal to terminate fetuses with severe genetic disorders such as thalassemia.

Abortion is currently prohibited in the UAE unless it is to save the life of the mother. But some Islamic scholars argue that abortion of a diseased fetus is also allowed as long as it is younger than 120 days.

About one in 12 Emiratis carry the gene for thalassemia, a genetic disease characterized by the breakdown of oxygen-rich red blood cells, and other haemoglobinopathies.

Other than thalassemia and sickle cell anemia, genetic disorders that may be also eligible for abortion include Trisomy 21 or Down's syndrome, caused by triplication of the 21st chromosome, said Shakar.

Source-IANS/M
'"/>




Page: 1

Related medicine news :

1. Legalization Of Euthanasia Would Not Affect Patient’s Trus
2. Legalization of Abortion in Mexico City Raises Heckles
3. Understanding Chronic Infections May Help in Developing Therapeutic Vaccines
4. Therapeutic cloning by regenerating stem cells from heart muscles
5. Therapeutic Genes Transferred By Viral Vector Through T Cell Masking
6. Therapeutic Monoclonal Antibody Production Is More Profitable Than Small Molecule Drugs
7. Functional Differences In Estrogen Receptor Could Be A Therapeutic Target
8. Clinical-trials Show Increased Therapeutic Activity of Pycnogenol than Daflon
9. Safety of Cancer Therapeutic Viruses Enhanced
10. Researchers Enhance Safety and Effectiveness of Therapeutic Virus that Fights Cancer
11. Human Embryonic Stem Cells Could Be Later Used In Therapeutic Cloning
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2016)... ... February 08, 2016 , ... Guruji Mahendra Kumar Trivedi is ... 11th, 2016 in honor of his birthday on February 10th. During this time, ... Trivedi is known by over 250,000 people from over 40 different countries as an ...
(Date:2/8/2016)... ... February 08, 2016 , ... According to research by the ... dental technicians to be certified or obtain continuing education. To increase patient awareness ... In Your Mouth?” campaign to inform dentists and patients about the possible lack ...
(Date:2/7/2016)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) , ... February 07, ... ... women on Friday in recognition of National Wear Red Day. National Wear Red ... heart disease and stroke in women. Heart disease and stroke cause 1 in 3 ...
(Date:2/7/2016)... ... 2016 , ... Dr. Todd Hobgood , certificated in ... surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, Kybella® ... for reduction of fat below the chin (aka the “double chin”). Medication side ...
(Date:2/6/2016)... ... 2016 , ... US Sports Camps is proud to sponsor the Bay Area ... top non-profit leaders, ultimate organizations, and coaches from around the US. The theme for ... Program Director of Youth and Education, describes this year YUCC as “an important conversation ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016 ... the addition of the "Label-Free Detection ... Forecasts to 2020" report to their ... announced the addition of the "Label-Free ... Global Forecasts to 2020" report to ...
(Date:2/8/2016)... , Feb. 8, 2016  Unilife Corporation ("Unilife" or "Company") ... of injectable drug delivery systems, today announced that it will ... ended December 31, 2015 after market close on February 9, ... conference call to discuss these financial results.    ... --> About Unilife Corporation ...
(Date:2/8/2016)... 8, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... announced that the U.S. Food and Drug Administration ... (IND) application for SB-318, a single treatment strategy ... Type I (MPS I). The SB-318 IND application ... a Phase 1/2 clinical study (SB-318-1502) designed to ...
Breaking Medicine Technology: